Compare RKLB & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKLB | A |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8B | 39.8B |
| IPO Year | N/A | N/A |
| Metric | RKLB | A |
|---|---|---|
| Price | $74.50 | $126.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $65.91 | ★ $165.13 |
| AVG Volume (30 Days) | ★ 19.0M | 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.83% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.33 | $8.03 |
| Revenue Next Year | $49.82 | $6.22 |
| P/E Ratio | ★ N/A | $27.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.71 | $96.43 |
| 52 Week High | $99.58 | $160.27 |
| Indicator | RKLB | A |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 37.67 |
| Support Level | $65.00 | $122.99 |
| Resistance Level | $76.80 | $129.98 |
| Average True Range (ATR) | 6.57 | 3.60 |
| MACD | -1.21 | -0.45 |
| Stochastic Oscillator | 41.77 | 34.74 |
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.